Deck 4: Generalized Anxiety Disorder GAD

Full screen (f)
exit full mode
Question
Which of the following is not one of the diagnostic symptoms of GAD listed in DSM-5?

A) Feeling on edge
B) Irritability
C) Low mood
D) Sleep disturbance
Use Space or
up arrow
down arrow
to flip the card.
Question
Which of the following is one of the key features that distinguishes worry in GAD from normal worry?

A) It temporarily reduces anxiety.
B) The content of the worry.
C) The individual feels that they cannot control the worry.
D) The worry is carried out in a ritualized and mechanical way.
Question
Which of the following is not a negative prognostic indicator for recovery from GAD discussed in the chapter?

A) Length of illness.
B) Difficult family relationships.
C) Comorbid personality disorder.
D) Stressful life events.
Question
In one etiological model of GAD, worry is considered to be part of constructive problem-focused coping in healthy individuals. In this model, individuals who go on to develop GAD …

A) Have parents with high levels of negative expressed emotion.
B) Lack confidence in their ability to solve problems.
C) Have high levels of neuroticism.
D) Lack serotonin receptors in key areas of the brain.
Question
Type 2 or "meta" worry is …

A) Globalized worry about all aspects of life.
B) Worry about individuals that one is close to.
C) Worry regarding things that one has no control over (e.g., world events).
D) Worry about worrying itself.
Question
Which of the following is not a brain region widely held to be associated with GAD?

A) Basal ganglia
B) Amygdala
C) Cerebellum
D) Superior temporal gyrus
Question
Most people who develop GAD do so before they are 20 years old.
Question
Which of the following is a drawback of treating GAD with benzodiazepines?

A) Longer delay before onset of clinical action as compared with SSRIs
B) Less short-term clinical efficacy than CBT
C) Risk of long-term tolerance
D) High rate of sexual side effects
Question
Which of the following is the best overall summary of research on the efficacy of new CBT variants for treating GAD?

A) More work is needed to understand what treatment components are effective.
B) None have shown promise.
C) Non-CBT derived treatments consistently outperform them.
D) They are rarely informed by etiological models of GAD.
Question
Which of the following is not a common component of CBT treatment for GAD?

A) Relaxation training.
B) Imaginal exposure.
C) Monitoring cues and triggers for worry.
D) In-session induction of somatic symptoms.
Question
Research on GAD has suffered due to:

A) Lack of interest among the academic community
B) Consistent exclusion of participants due to comorbid substance abuse disorder
C) Unreliable and changing diagnostic status of GAD
D) None of the above
Question
Although research findings have been largely inconclusive, which of the following neurotransmitters has been studied and potentially implicated in GAD?

A) Serotonin
B) GABA
C) Cortisol
D) All of the above
Question
Which of the following is the best-studied psychological intervention for GAD?

A) Cognitive Behavioral Therapy (CBT)
B) Behavioral Activation (BA)
C) Dialectical Behavior Therapy (DBT)
D) Mentalization Based Therapy
Question
In reviews of pharmacotherapy for GAD, which pharmacological treatment is considered as the "first-line therapy" for GAD?

A) Benzodiazepines
B) Selective Serotonin Reuptake Inhibitors (SSRIs)
C) Buspirone
D) Second-generation antipsychotic medications
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/14
auto play flashcards
Play
simple tutorial
Full screen (f)
exit full mode
Deck 4: Generalized Anxiety Disorder GAD
1
Which of the following is not one of the diagnostic symptoms of GAD listed in DSM-5?

A) Feeling on edge
B) Irritability
C) Low mood
D) Sleep disturbance
C
2
Which of the following is one of the key features that distinguishes worry in GAD from normal worry?

A) It temporarily reduces anxiety.
B) The content of the worry.
C) The individual feels that they cannot control the worry.
D) The worry is carried out in a ritualized and mechanical way.
C
3
Which of the following is not a negative prognostic indicator for recovery from GAD discussed in the chapter?

A) Length of illness.
B) Difficult family relationships.
C) Comorbid personality disorder.
D) Stressful life events.
A
4
In one etiological model of GAD, worry is considered to be part of constructive problem-focused coping in healthy individuals. In this model, individuals who go on to develop GAD …

A) Have parents with high levels of negative expressed emotion.
B) Lack confidence in their ability to solve problems.
C) Have high levels of neuroticism.
D) Lack serotonin receptors in key areas of the brain.
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
5
Type 2 or "meta" worry is …

A) Globalized worry about all aspects of life.
B) Worry about individuals that one is close to.
C) Worry regarding things that one has no control over (e.g., world events).
D) Worry about worrying itself.
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
6
Which of the following is not a brain region widely held to be associated with GAD?

A) Basal ganglia
B) Amygdala
C) Cerebellum
D) Superior temporal gyrus
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
7
Most people who develop GAD do so before they are 20 years old.
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
8
Which of the following is a drawback of treating GAD with benzodiazepines?

A) Longer delay before onset of clinical action as compared with SSRIs
B) Less short-term clinical efficacy than CBT
C) Risk of long-term tolerance
D) High rate of sexual side effects
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
9
Which of the following is the best overall summary of research on the efficacy of new CBT variants for treating GAD?

A) More work is needed to understand what treatment components are effective.
B) None have shown promise.
C) Non-CBT derived treatments consistently outperform them.
D) They are rarely informed by etiological models of GAD.
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
10
Which of the following is not a common component of CBT treatment for GAD?

A) Relaxation training.
B) Imaginal exposure.
C) Monitoring cues and triggers for worry.
D) In-session induction of somatic symptoms.
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
11
Research on GAD has suffered due to:

A) Lack of interest among the academic community
B) Consistent exclusion of participants due to comorbid substance abuse disorder
C) Unreliable and changing diagnostic status of GAD
D) None of the above
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
12
Although research findings have been largely inconclusive, which of the following neurotransmitters has been studied and potentially implicated in GAD?

A) Serotonin
B) GABA
C) Cortisol
D) All of the above
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
13
Which of the following is the best-studied psychological intervention for GAD?

A) Cognitive Behavioral Therapy (CBT)
B) Behavioral Activation (BA)
C) Dialectical Behavior Therapy (DBT)
D) Mentalization Based Therapy
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
14
In reviews of pharmacotherapy for GAD, which pharmacological treatment is considered as the "first-line therapy" for GAD?

A) Benzodiazepines
B) Selective Serotonin Reuptake Inhibitors (SSRIs)
C) Buspirone
D) Second-generation antipsychotic medications
Unlock Deck
Unlock for access to all 14 flashcards in this deck.
Unlock Deck
k this deck
locked card icon
Unlock Deck
Unlock for access to all 14 flashcards in this deck.